Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease.

The purpose of this Special Issue is to present the impact in clinical practice as well as in medical research of novel molecules that have been introduced in the treatment of diabetes mellitus, dyslipidaemia, and cardiovascular disease. Included in the topic is also the presentation of certain novel molecules such as derivatives of quinopimaric acid, useful in the inhibition of some enzymes involved in the glucose metabolism, or what is also presented is novel applications of the administration of older molecules (such as nicotinamide) for the inhibition of the key pathogenetic processes involved in diabetes complications. [Extracted from the article]